Utility of SPECT/CT as an Adjunct to Planar Whole Body I-131 Imaging: Liver Metastasis from Papillary Thyroid Cancer

Clinical Nuclear Medicine

Volumn 34, Issue 4, 2009, Pages 247-248

  Agriantonis, Demetrios J ^a,b   Hall, Lance ^a   Wilson, Michael A ^a  

^a University of Wisconsin Health   (United States)

^b USA   (United States)

Author keywords

I 131; Papillary thyroid carcinoma liver metastasis; SPECT CT

Indexed keywords

IODINE 131;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; LIVER METASTASIS; MALE; PROGNOSIS; RADIOFREQUENCY ABLATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY IMAGING;

DIAGNOSTIC IMAGING; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 67650637702     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31819a1eb3     Document Type: Article

References (15)

1. 131I in the treatment of well differentiated thyroid cancer. J Surg Oncol. 2005;89:114-121.
2. 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab. 2007;92:28-38.
3. Yamamoto Y, Nishiyama Y, Monden T, et al. Clinical usefulness of fusion of I-131 SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med. 2003;44:1905-1910.
4. Tharp K, Israel O, Hausmann J, et al. Impact of I-131 SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:1435-1442.
5. Ruf J, Lehmkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun. 2004;25:1177-1182.
6. Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003;33:205-218.
7. Hindi E, Zanotti-Fregonara P, Keller I, et al. Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome. Endocrine Relat Cancer. 2007;14:799-807.
8. Shoup M, Stojadinovic A, Nissan A, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg. 2003;197:191-197.
9. Chiu A, Delpassand E, Sherman S. Prognosis and treatment of brain metas-tases in thyroid carcinoma. J Clin Endocrinol Metab. 1997;82:3637-3642.
10. Mishra A, Mishra S, Das B, et al. Differentiated thyroid cancer presenting as distant metastases. Eur J Surg. 2002;168:305-309.
11. Ruegemer J, Hay I, Bergstralh E, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 1988;67:501-508.
12. Von Falck C, Beer G, Gratz K, et al. Renal metastases from follicular thyroid cancer on SPECT/CT. Clin Nucl Med. 2007;32:751-752.
13. Dinneen S, Valimaki M, Bergstralh E, et al. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab. 1995;80:2041-2045.
14. Carlisle MR, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun. 2003;24:715-735.
15. Pardo F, de la Jara A, Morejon F, et al. Solitary focus in the liver in a thyroid cancer patient after a whole body scan with 131 iodine. Rev Esp Med Nucl. 2007;26:294-296.